3-D Matrix, Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMTRF research report →
About the company
3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications.
- CEO
- Keiji Nagano
- IPO
- 2013
- Employees
- 106
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $270.48M
- P/E
- 10.24
- P/S
- 3.94
- P/B
- 6.43
- EV/EBITDA
- 13.69
- Div Yield
- 0.00%
- Gross Margin
- 78.74%
- Op Margin
- 12.27%
- Net Margin
- 38.17%
- ROE
- 89.26%
- ROIC
- 17.95%
- Revenue
- $10.87B · 56.74%
- Net Income
- $4.15B · 265.88%
- EPS
- $34.41 · 236.55%
- Op Income
- $1.33B
- FCF YoY
- 121.33%
- 52W High
- $3.96
- 52W Low
- $0.69
- 50D MA
- $3.04
- 200D MA
- $2.63
- Beta
- 0.99
- Avg Volume
- 40
Get TickerSpark's AI analysis on DMTRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our DMTRF coverage
Recent articles, reports, and earnings notes.
No research on DMTRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMTRF report →Similar companies
Peers in the same neighborhood.